“Antibody vs. T Cell Immunity: Is a Single Vaccine Enough to Stop COVID-19?”, a Virtual Webinar and Q&A, on September 24th at 10 a.m., hosted by Tonix Pharmaceuticals, will dive into the concept of two types of immune responses and provide an overview of the current vaccine development challenges. Join leading vaccine authorities in a […]

Brian Culley, CEO of Lineage Cell Therapeutics, a clinical-stage biotechnology company, discusses the three cell therapy programs they currently have in clinical trials: OpRegen – a cell replacement therapy for the treatment of advanced dry age-related macular degeneration (dry AMD), OPC1 – a cell replacement therapy for the treatment of acute spinal cord injuries, and […]

Dr. Maxime Descoteaux, Co-founder and CSO of Imeka, “the only company to combine diffusion and AI to map white matter integrity” discusses the use of white matter free water biomarker in Alzheimer’s disease and why scientists should change their focus from grey matter to white matter when it comes to evaluating Alzheimer’s disease.  He also […]